Skip to main content
. 2017 Dec 7;26(2):224–231. doi: 10.1016/j.jsps.2017.12.007

Table 4.

Relative antihyperlipidemic biomarkers activity of CUB-F1 to fluvastatin drug.

Biomarkers Relative%
TC 94.42
TG 78.16
Total Lipids 98.23
GSH 101.99
TAC 126.44
MDA 102.35
NO 90.23
ICAM 95.91
VCAM 81.64
MAO 84.89

Activity > 75% high, 75–50%: good, 50–25%: normal, <25%: weak activity.